Frontlight ResearchEarly access
Huntington's disease trials in Netherlands
4 of 7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in NetherlandsPridopidine Phase 3 Study in Huntington's Disease
- Where
- Leiden
- Age
- 23 years to 65 years
- People
- 400 worldwide
- Run by
- Prilenia
See details and how to joinNCT07609108 · EU 2026-526093-16-00 - Phase 2Not yet taking people in NetherlandsA Phase 2, open-label trial to investigate the long-term safety of VO659 administered intrathecally in participants with Huntington’s disease and spinocerebellar ataxia type 1 and 3
- Where
- Leiden, Maastricht, Nijmegen
- Age
- 18 years to 64 years
- People
- 60 worldwide
- Run by
- Vico Therapeutics B.V.
See details and how to join2026-526408-60-00 - Phase 3Taking peopleA Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
- Where
- Leiden, Maastricht
- Age
- 21 years to 70 years
- People
- 770 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07326709 · EU 2025-522227-99-00 - Phase 1/2Taking peopleA Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
- Where
- Leiden, Maastricht, Nijmegen
- Age
- 25 years to 60 years
- People
- 68 worldwide
- Run by
- Vico Therapeutics B. V.
See details and how to joinNCT05822908 · EU 2024-514328-18-00